PAGE

Partner Therapeutics' Leukine® (sargramostim) Receives Approval in Japan to Treat Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

Retrieved on: 
Mercredi, avril 3, 2024
Monocyte, GM, Serum, Disease, Partnership, Patient, GM-CSF, DNA, PTX, Doctor of Philosophy, Respiratory failure, Pleasure, Trade name, Granulocyte-macrophage colony-stimulating factor, Pulmonary fibrosis, APAP, Therapy, Niigata University, Pulmonary alveolar proteinosis, Division, Partner, PMDA, PAGE, CEA, WLL, Hospital

LEXINGTON, Mass., April 3, 2024 /PRNewswire/ -- Partner Therapeutics, Inc. (PTx) announced that its partner Nobelpharma received approval from the Japanese Pharmaceuticals and Medical Device Agency (PMDA) for the inhaled use of Leukine (sargramostim), branded in Japan as Sargmalin, to treat aPAP. PTx licensed rights for certain indications in Japan to Nobelpharma in 2022. Leukine is a glycosylated recombinant human granulocyte-macrophage colony-stimulating factor (rhu GM-CSF) produced by recombinant DNA technology in yeast. Leukine is not approved outside Japan for aPAP or as an inhalation therapy. Partner Therapeutics will manufacture Sargmalin for Nobelpharma at its manufacturing facility in Lynnwood, WA.

Key Points: 
  • Leukine is not approved outside Japan for aPAP or as an inhalation therapy.
  • Partner Therapeutics will manufacture Sargmalin for Nobelpharma at its manufacturing facility in Lynnwood, WA.
  • Inhaled recombinant GM-CSF reduces the need for whole lung lavage and improves gas exchange in autoimmune pulmonary alveolar proteinosis patients.
  • Autoimmune pulmonary alveolar proteinosis.

New Jersey Natural Gas Files Base Rate Case With the New Jersey Board of Public Utilities

Retrieved on: 
Mercredi, janvier 31, 2024
Oil, Gas, Energy, Environment, Sustainability, Utilities, BPU, Natural gas, USF, BGSS, Public, Safety, Carbon, Investment, New Jersey Resources, Universal Service Fund, PAGE, LIHEAP, Sale, Heat, NJR, Customer service

New Jersey Natural Gas (NJNG), the principal subsidiary of New Jersey Resources (NYSE: NJR), filed a petition with the New Jersey Board of Public Utilities (BPU) requesting an increase of $222.6 million to its base rates.

Key Points: 
  • New Jersey Natural Gas (NJNG), the principal subsidiary of New Jersey Resources (NYSE: NJR), filed a petition with the New Jersey Board of Public Utilities (BPU) requesting an increase of $222.6 million to its base rates.
  • The second is the Basic Gas Supply Service (BGSS), which covers the cost of purchasing natural gas.
  • The delivery charge covers the cost of providing safe, reliable natural gas service to customers and maintaining operations and delivery systems.
  • Any customer having difficulty paying their natural gas bill should visit njng.com/energyassistance to learn about available energy assistance programs.

Checkpoint Therapeutics Announces Presentation of New Cosibelimab Pharmacokinetic Data Supporting Extended-Interval Dosing

Retrieved on: 
Mercredi, juin 28, 2023
PK, Biologics license application, Additive effect, Marketing, CKPT, Food and Drug Administration, U.S. FDA, Patient, Carcinoma, PDUFA, PAGE, FDA, BLA, Food, Pharmaceutical industry, Generic drug

WALTHAM, Mass., June 28, 2023 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that new pharmacokinetic (“PK”) modeling data on cosibelimab supporting the extension to an every-three-week dosing regimen were presented today at the Population Approach Group Europe (“PAGE”) 2023 annual meeting, taking place in A Coruña, Spain.

Key Points: 
  • The poster presentation, entitled “Population Pharmacokinetic Analysis of PD-L1 Checkpoint Inhibitor Cosibelimab in Subjects with Advanced Cancers,” compares cosibelimab exposures from over 200 patients enrolled in the multicenter, multiregional pivotal trial of cosibelimab in which cohorts of patients were dosed at either 800 mg every two weeks (“Q2W”) or 1200 mg every three weeks (“Q3W”).
  • The patient exposure results provide evidence that cosibelimab dosed at 800 mg Q2W and 1200 mg Q3W intervals are comparable based on the PK-related criteria outlined in U.S. Food and Drug Administration (“FDA”) guidance for supporting alternative dosing regimens for PD-L1 antibodies.
  • These data support the proposed 1200 mg Q3W commercial dosing regimen for cosibelimab included in the Biologics License Application (“BLA”) for advanced cutaneous squamous cell carcinoma currently under review by the FDA with a Prescription Drug User Fee Act (“PDUFA”) goal date of January 3, 2024.
  • Mr. Oliviero continued, “These data further support the comparability of the two-week and three-week dosing regimens for cosibelimab and are included in the BLA submission currently under FDA review.

JCP&L Encourages Customers to Arrange Payment Plans and Apply for Bill Assistance Programs

Retrieved on: 
Mardi, janvier 17, 2023
Heat, Face, FirstEnergy, Universal Service Fund, Safety, JCP, NYSE, LIHEAP, FE, Gas, ZIP, PAGE, USF, Multimedia, Electricity, NJ, Health insurance, Online shopping

MORRISTOWN, N.J., Jan. 17, 2023 /PRNewswire/ -- Residential customers of Jersey Central Power and Light (JCP&L), a subsidiary of FirstEnergy Corp. (NYSE: FE), who are having difficulty making ends meet are encouraged to contact their utility now to enroll in payment plans or to receive referrals for bill assistance programs.

Key Points: 
  • Programs customers may be eligible to participate in include:
    The Universal Service Fund (USF) Program: Eligible customers can receive a monthly bill credit and may also receive utility debt forgiveness.
  • The Low-Income Heating Energy Assistance Program (LIHEAP): This program may help low-income customers meet home heating and medically necessary cooling costs.
  • 2-1-1 Helpline: This nationwide resource and information helpline identifies locally available programs that may assist customers with utility bills or other needs.
  • For a complete list of assistance programs for which customers may be eligible, including installment payment plans and budget billing, please visit www.firstenergycorp.com/billassist or call customer service at 1-800-662-3115.

Children's Hospital of Philadelphia Joins Forces with Gilbane Building Company, Pride Enterprises, and McKissack & McKissack to Create State-of-the-Art Pediatric Research Building

Retrieved on: 
Jeudi, octobre 13, 2022
Time, Coffeehouse, Commerce, Gilbane Building Company, Life, Hospital, Growth, South Street Bridge (Philadelphia, Pennsylvania), Navy Yard, McKissack, Pediatric Research, Research, Workforce, Prussia, Construction, McKissack & McKissack, Children's Hospital of Philadelphia, Senior, CHOP, Sport, General contractor, Industry, Health, Ownership, Gilbane, Inc., Safety, Environment, City, Government, Real estate, PAGE, Center, Roberts Center, Medicine, Retail, Interior design, Child, Pride

PHILADELPHIA, Oct. 13, 2022 /PRNewswire/ -- In an effort to create the pediatric research building of the future, Children's Hospital of Philadelphia (CHOP) has joined forces with Gilbane Building Company, Pride Enterprises, and McKissack & McKissack to construct the Schuylkill Avenue Research Building. The tri-venture Gilbane/Pride/McKissack will provide construction management services to build a state-of-the-art research facility, where researchers from different disciplines can collaborate and make discoveries that will define the next century of pediatric healthcare.  

Key Points: 
  • PHILADELPHIA, Oct. 13, 2022 /PRNewswire/ -- In an effort to create the pediatric research building of the future, Children's Hospital of Philadelphia (CHOP) has joined forces with Gilbane Building Company , Pride Enterprises , and McKissack & McKissack to construct the Schuylkill Avenue Research Building.
  • Situated next to the Roberts Center for Pediatric Research, the new 14-story, 350,000-square-foot building will have many spaces designed to encourage scientific collaboration.
  • About Children's Hospital of Philadelphia:A non-profit, charitable organization, Children's Hospital of Philadelphia was founded in 1855 as the nation's first pediatric hospital.
  • McKissack has offices in New York and Philadelphia, as well as regional offices across the country including Boston and North Carolina.

Energy Companies, Climate Advocates and Labor Groups Launch Coalition to Expand Natural Gas Production to Replace Foreign Coal, Lower GHG Emissions

Retrieved on: 
Mardi, octobre 11, 2022
Natural Resources, Environment, Other Manufacturing, State, Local, Environmental, Social and Governance (ESG), Public Policy, Environmental Policy, Environmental Issues, Engineering, Environmental Health, Labor, Manufacturing, Advocacy Group Opinion, Public Policy, Government, Other Energy, Utilities, Oil, Gas, Coal, Alternative Energy, Energy, Climate Change, Thought Leadership, Sustainability, Professional Services, Green Technology, Other Natural Resources, Hydrogen, Trade, Union, Democrat, Progressive Policy Institute, Climate, GHG, Coal, Electricity, Public sector, Natural gas, McManus, TC Energy, Organization, United Association, Economics, General officer, Carbon, Pipefitter, EQT, Consumer green energy program, Potsdam Institute for Climate Impact Research, Industry, CEO, UA, Atlantic Council, Â, Wind, Research, PAGE, Stanford University, Hearing, Partnership, Methane, CO2, Renewable energy, Management, LNG

A coalition of responsible energy companies, leading climate advocates and labor groups today formally launched the Partnership to Address Global Emissions (PAGE).

Key Points: 
  • A coalition of responsible energy companies, leading climate advocates and labor groups today formally launched the Partnership to Address Global Emissions (PAGE).
  • PAGE will advocate for policies that enable the development of the infrastructure needed to increase production and export of U.S. liquefied natural gas (LNG) to replace foreign coal and lower greenhouse gas (GHG) emissions.
  • Over the past 15 years, the U.S. has led the world in GHG emissions reductions, driven in large part by switching electricity production from coal to natural gas, which generates considerably fewer CO2 emissions.
  • Partnership to Address Global Emissions (PAGE) is a coalition of responsible energy companies, labor unions and leading climate advocates dedicated to promoting U.S. policies that protect the climate, strengthen the economy, lower energy costs and bolster energy security through the production and export of cleaner natural gas.

Simulations Plus Presented New Scientific Developments at PAGE 2022

Retrieved on: 
Mardi, juillet 26, 2022
Software, Research, General Health, Pharmaceutical, Oncology, Data Management, Technology, Public Relations, Investor Relations, Science, Communications, Other Science, Health, U.S. Securities and Exchange Commission, Decision-making, SLP, PAGE, Research, LinkedIn, Drug discovery, Solution, Software, Private Securities Litigation Reform Act, Mission statement, Data analysis, Economics, Adoption, Nonlinear mixed-effects model, Biotechnology, Technology, Company, Simulations Plus, Nasdaq, Pharmacokinetics, Survival, ESG, Risk, Biophysical environment, Population, Medical device

Simulations Plus , Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced the presentation of five scientific posters by Simulations Plus scientists at the Population Approach Group in Europe (PAGE) conference held in Ljubljana , Slovenia from June 28 to July 1, 2022.

Key Points: 
  • Simulations Plus , Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced the presentation of five scientific posters by Simulations Plus scientists at the Population Approach Group in Europe (PAGE) conference held in Ljubljana , Slovenia from June 28 to July 1, 2022.
  • Since 1992, the PAGE conference has brought together a scientific community with a shared interest in data analysis using the population approach.
  • This years meeting took place in an informal setting where more than 600 scientists gathered to engage in vibrant scientific discussions.
  • Dr. Jonathan Chauvin , President of the Lixoft division at Simulations Plus, said: After a two-year hiatus, we were eager to attend this face-to-face meeting, and Simulations Plus products and services were well represented.

Lexia Learning Launches Customer Advisory Board to Deepen Educator Insights, Relationships, and Collaboration

Retrieved on: 
Lundi, août 23, 2021
Technology, Parenting, Consulting, Other Technology, Professional Services, Internet, University, Consumer, Primary, Secondary, Education, Learners, Student, Literacy, Partner, Leadership, DOE, Research, Charter Schools USA, Bloom, Little Rock School District, Solution, CSUSA, Prince, Our Girl, Worcester Public Schools, Anaheim Elementary School District, ESOL, Lexia, MAP, Learning, K-12, Element, Twitter, Language acquisition, Prince William County Public Schools, NSBA, Professional association, Language, University of Florida College of Education, PAGE, Syracuse City School District, Door, LinkedIn, Chicago Public Schools, Education, NWEA, Achievement, Curriculum, Roman Catholic Archdiocese of New Orleans, Customer advisory council, Tutoring, Management, Lexia Learning, Cambium Learning Group, LEXIA LEARNING, CAMBIUM LEARNING GROUP

Lexia Learning, a Cambium Learning Group company, today announced the formation of its customer advisory board, a group of key customers who will support the companys goal of helping more learners read, write, and speak with confidence.

Key Points: 
  • Lexia Learning, a Cambium Learning Group company, today announced the formation of its customer advisory board, a group of key customers who will support the companys goal of helping more learners read, write, and speak with confidence.
  • The Customer Advisory Board consists of school district leadership from across the United States:
    Lynmara Coln is the director of English learner programs and services at Prince William County Schools in Virginia.
  • With robust offerings for differentiated instruction, personalized learning, assessment, and professional learning, Lexia helps more learners read, write, and speak with confidence.
  • The Cambium family of companies includes: Cambium Assessment, Lexia Learning, Learning A-Z, Voyager Sopris Learning, ExploreLearning, Time4Learning, and Kurzweil Education.